TOXIC
Dedy Rahmat Syahir C 111 10 174
Muh. Ikbal Lungge C 111 12 133
• Patients come to the hospital with complaints swelling at the neck between right and left
especially at the right neck with length about 10 cm and a width about 15 cm had felt since
about 10 years ago and slow increasingly swelling. The mass is not pain especially on
swallowing, no hoarse, color like skin, flat and smooth surface, warm, solid consistency, no
fever, no shortness on breathing, no cough, no chest pain, no excessive sweating, no weight loss
and, defecation is normal once a day, solid and yellow, no history with black feces. Urinating is
normal, yellow clear color.
• There is a history with diabetes mellitus since one year ago and was treated with insulin
injections, history of hypertension since 5 years ago and no medical treatment, There is no
previous treatment history, and no family history of complaints for the same disease.
Physical Examination
• Weight : 59 Kg
• Height : 155 cm
• BMI : 24,5 kg/m2
PHYSICAL EXAMINATION
• Head : Within normal limit (WNL)
• Eyes : Icteric sclerae (-) Pupil φ2mm/2mm isochor
Anemic conjunctiva (-) Movement : WNL
• Ear : WNL
• Nose : WNL
• Mouth : Lips, teeth and gums WNL
Tonsil no hyperemia
Pharnyx no hyperemia
Tongue WNL (there’s no dirty tongue)
• Skin : Vasculitis (-), Petechie (-)
PHYSICAL EXAMINATION
• Neck :
- Thyroid gland :
Inspection: Nodule between on the right and left neck
especially on the right, length of 10 cm and a width of 15 cm,
not pain, skin like color, not move on swallowing
Palpation: solid consistency, flat surface, warm, not fixed, not
pain on pressure
1.Nodule between on the right and • Struma Nodulus Non Toxic • Thyroidectomy
left neck especially on the right,
length of 10 cm and a width of 15
cm, not pain, not pain on
swallowing, no hoarse, skin like
color, not move on swallowing,
solid consistency, flat surface,
warm, not fixed, not pain on
pressure
www.ncbi.nlm.nih.gov/pmc/articles/PMC4876491/
ETIOLOGY
• Iodine deficiency
• Goitrogenic factor
• Iodine overage
• Genetic, etc
• Nutritions
Swelling of gland
Struma/Goiter
• A family history of thyroid • Age under 20 years or up to 70 • A family history with benign
carcinoma medulare years old module
• Rapidly enlarge especially in • A history of radiaton on head • Difuse struma or multinodosa
Levothyroxine therapy and neck • Fixed amount
• Dense and hard nodule • Nodule > 4 cm or partially cystic • FNA: Benign
• Attached to the surrounding • Complain on pressure, • Simplex Cyst
tissue dysphagia, dysphonia, hoarse, • Warm or hot nodules
• Paralysis of the vocal cord dyspnea, and cough • Wane on Suppresive
• Regional Lymphadenopathy Levothyroxine therapy
• Distant metastasis
journals.lww.com/theendocrinologist/Fulltext/2003/01000/Nont
oxic,_Nodular_Goiter__New_Management_Paradigms.8.aspx
TNM CLASSIFICATION
PRIMARY TUMOR (T)
TX Primary tumor cannot be assessed
T0 No evidence of primary tumor is found
T1 Tumor size ≤ 2 cm in greatest dimension and is limited to the thyroid
T1a Tumor ≤ 1 cm, limited to the thyroid
T1b Tumor > 1 cm but ≤ 2 cm in greatest dimension, limited to the thyroid
T2 Tumor size > 2 cm but ≤ 4 cm, limited to the thyroid.
T3 Tumor size >4 cm, limited to the thyroid or any tumor with minimal extrathyroidal extension (eg,
extension to sternothyroid muscle or perithyroid soft tissues)
T4a Moderately advanced disease; tumor of any size extending beyond the thyroid capsule to invade
subcutaneous soft tissues, larynx, trachea, esophagus, or recurrent laryngeal nerve
T4b Very advanced disease; tumor invades prevertebral fascia or encases carotid artery or mediastinal
vessel
http://emedicine.medscape.com/article/2006643-overview
STAGING
REGIONAL LYMPH NODES (N)
NX Regional nodes cannot be assessed
T0 No regional lymph node metastasis
N1 Regional lymph node metastasis
N1a Metastases to level VI (pretracheal, paratracheal, and prelaryngeal/Delphian lymph nodes)
N1b Metastases to unilateral, bilateral, or contralateral cervical (levels I, II, III, IV, or V) or
retropharyngeal or superior mediastinal lymph nodes (level VII)
http://emedicine.medscape.com/article/2006643-overview
STAGE GROUPING
PAPILLARY AND FOLLICULAR THYROID CANCER (AGE < 45Y)
STAGE T N M
I Any T Any N M0
II Any T Any N M1
Surgery
www.ncbi.nlm.nih.gov/pmc/articles/PMC4876491/
Treatment Advantages Disadvantages Comments
Levothyroxine Outpatient use Low efficacy Declining due to adverse effects and lack of
Low cost Main effect on perinodular volume efficacy
Prevent formation of other nodules? Continuous suppression of TSH, which leads
to side events associated with subclinical
hyperthyroidism, as well as unpredictable
bone and cardiac side effects
Surgery Substantial reduction in goiter size Not applicable to all individuals Standard treatment for large goiters or when
Rapid relief of compression of vital cervical Post-surgical hemorrhage (1%) rapid decompression of cervical structures is
structures Damage to the recurrent laryngeal nerve (1– required
Allows pathological assessment 2%) Total thyroidectomy should be considered the
Temporary (0.5%) or definitive (0.6%) preferred therapy to prevent goiter
hypoparathyroidism recurrence
Goiter recurrence depending on the extent of
resection
Post-surgical tracheomalacia (rare)
Increased morbidity in cases with large
goiters, intrathoracic extension or reoperation
Radioiodine Thyroid volume reduction by half in 1 year Gradual reduction in goiter size In some European countries, radioiodine has
Improves respiratory capacity in the long term The larger the goiter, the lower the effect become the standard therapy, replacing
Frequent outpatient use Slight risk of short-term increase in goiter size surgery
Can be successfully repeated 3% risk of thyroiditis May be considered in place of surgical
Few side effects 5% risk of development of Graves’ disease intervention in patients who refuse or are
15–20% risk of hypothyroidism at 12 months unable to undergo surgery, or in those with
Small risk of radiation-induced large goiters (except in cases that require
ophthalmopathy large radioiodine doses)
Requires retreatment in some cases Can be preceded by rhTSH with lower
Risk of radiation-induced malignancy has not radioiodine dose
been established
THANK YOU